Argonaute RNA
Biotech·
United Kingdom·Active·New
United Kingdom·Active·NewEntry
2026
Hold
New
Status
Active
Who owns Argonaute RNA?
Argonaute RNA is a British Biotech company, currently owned by Parkwalk Advisors since 2026.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
More from Parkwalk Knowledge Intensive EIS Fund
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Argonaute RNA?
Argonaute RNA is currently owned by Parkwalk Advisors, through Parkwalk Knowledge Intensive EIS Fund, since 2026.
When did Parkwalk Advisors acquire Argonaute RNA?
Parkwalk Advisors acquired Argonaute RNA in 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue